+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

SDS Poly Acrylamide Gel Electrophoresis - Global Strategic Business Report

  • PDF Icon

    Report

  • 151 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5140319
The global market for SDS Poly Acrylamide Gel Electrophoresis was estimated at US$544.9 Million in 2025 and is projected to reach US$805.8 Million by 2032, growing at a CAGR of 5.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global SDS Poly Acrylamide Gel Electrophoresis Market - Key Trends and Drivers Summarized

SDS Poly Acrylamide Gel Electrophoresis: How Is It Shaping Proteomics and Genomics Research?

SDS Poly Acrylamide Gel Electrophoresis (SDS-PAGE) is a fundamental technique in molecular biology and biochemistry used for the separation, identification, and analysis of proteins. This technique is widely utilized in research and development, clinical diagnostics, drug discovery, and quality control in various industries, including pharmaceuticals, biotechnology, and food and beverages. The SDS-PAGE market is expanding due to the rising demand for protein characterization in genomics and proteomics research, driven by increasing investments in life sciences and the growing focus on personalized medicine. The ability of SDS-PAGE to provide accurate and reproducible results in protein separation and analysis is making it an indispensable tool in academic and commercial laboratories worldwide.

How Are Technological Innovations Enhancing the Effectiveness of SDS-PAGE?

Technological innovations are significantly enhancing the effectiveness and efficiency of SDS-PAGE systems, driving their adoption in various research and industrial applications. The development of automated and high-throughput electrophoresis systems is enabling laboratories to process multiple samples simultaneously, reducing manual errors and improving workflow efficiency. Advances in gel preparation techniques, such as pre-cast gels and gradient gels, are simplifying the electrophoresis process, making it more accessible to researchers. Furthermore, innovations in staining and detection methods, including silver staining, Coomassie brilliant blue, and fluorescent dyes, are improving sensitivity and accuracy in protein visualization and quantification. These technological advancements are expanding the scope and applications of SDS-PAGE in molecular biology and proteomics.

What Market Trends Are Influencing the Demand for SDS-PAGE Systems?

Several market trends are influencing the demand for SDS-PAGE systems, reflecting the evolving needs of the scientific community. The increasing focus on clinical diagnostics and biomarker discovery is driving the use of SDS-PAGE in identifying disease-related proteins and developing targeted therapies. The growth of contract research organizations (CROs) and academic research institutions is expanding the demand for high-quality electrophoresis equipment that delivers precise results. Additionally, the rising emphasis on personalized medicine and proteomics is generating new opportunities for advanced SDS-PAGE systems capable of handling complex samples and providing detailed protein profiling. The emergence of portable and miniaturized electrophoresis devices is also expanding the market by making protein analysis more accessible in point-of-care settings.

What Drives the Growth in the SDS-PAGE Market?

The growth in the SDS-PAGE market is driven by several factors, including advancements in electrophoresis technologies, increasing applications in proteomics and clinical diagnostics, and growing investments in biotechnology research. The demand for high-throughput and automated SDS-PAGE systems is rising due to the need for efficient protein analysis in drug discovery and development. The expanding use of SDS-PAGE in food quality control, forensic analysis, and environmental monitoring is also contributing to market growth. Additionally, the growing focus on biomarker discovery and personalized medicine is driving the adoption of advanced electrophoresis techniques that offer higher sensitivity and accuracy. Collaboration between equipment manufacturers and research institutions to develop innovative solutions is further supporting market expansion.

Report Scope

The report analyzes the SDS Poly Acrylamide Gel Electrophoresis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Offering (Instruments Offering, Reagents Offering, Gels Offering); End-Use (Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use, Academic Institutes End-Use)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Instruments Offering segment, which is expected to reach US$363.5 Million by 2032 with a CAGR of a 5.6%. The Reagents Offering segment is also set to grow at 7.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $160.7 Million in 2025, and China, forecasted to grow at an impressive 5.6% CAGR to reach $143.5 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global SDS Poly Acrylamide Gel Electrophoresis Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global SDS Poly Acrylamide Gel Electrophoresis Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global SDS Poly Acrylamide Gel Electrophoresis Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abcam PLC, Analytik Jena AG, Bio-Rad Laboratories, Inc., EnCor Biotechnology, GenScript Biotech Corporation and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this SDS Poly Acrylamide Gel Electrophoresis market report include:

  • Abcam PLC
  • Analytik Jena AG
  • Bio-Rad Laboratories, Inc.
  • EnCor Biotechnology
  • GenScript Biotech Corporation
  • Lonza Bioscience
  • Lonza Group Ltd.
  • Novus Biologicals LLC
  • PhosphoSolutions, Inc.
  • Promega Corporation

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 3,894 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • SDS Poly Acrylamide Gel Electrophoresis - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Focus on Protein Analysis and Purification Drives Demand for SDS PAGE Systems
  • Growing Investments in Biotechnology and Pharmaceutical R&D Propel Market Growth
  • Technological Advancements in Electrophoresis Equipment Enhance Accuracy and Efficiency
  • Increasing Use of SDS PAGE in Academic Research Expands Addressable Market
  • Development of Automated and High-Throughput SDS PAGE Systems Spurs Adoption
  • Growing Emphasis on Clinical Diagnostics and Biomarker Discovery Supports Market Expansion
  • Rising Demand for Protein Characterization in Drug Development Boosts Market Growth
  • Increasing Focus on Personalized Medicine and Proteomics Propels Demand for SDS PAGE
  • Advances in Staining and Detection Techniques Enhance Market Potential
  • Rising Use of SDS PAGE in Food and Beverage Quality Control Sustains Market Demand
  • Emergence of Portable and Miniaturized Electrophoresis Systems Expands Market Reach
  • Growth in Genomics and Proteomics Research Generates Opportunities for Advanced SDS PAGE Solutions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World SDS Poly Acrylamide Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Reagents Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Reagents Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Reagents Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Gels Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Gels Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Gels Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Clinical Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Clinical Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Government Agencies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 29: USA Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: USA Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: USA 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 35: Canada Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: Canada Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: Canada 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
JAPAN
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 41: Japan Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 42: Japan Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: Japan 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
CHINA
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 44: China Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 47: China Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 48: China Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: China 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
EUROPE
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 56: Europe Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 57: Europe Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 58: Europe 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
FRANCE
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 59: France Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 62: France Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 63: France Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 64: France 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
GERMANY
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 68: Germany Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 69: Germany Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 70: Germany 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 74: Italy Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 75: Italy Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 76: Italy 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 80: UK Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 81: UK Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 82: UK 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 84: Rest of Europe Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 85: Rest of Europe 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 87: Rest of Europe Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 88: Rest of Europe 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • SDS Poly Acrylamide Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 90: Asia-Pacific Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 91: Asia-Pacific 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 93: Asia-Pacific Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 94: Asia-Pacific 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
REST OF WORLD
  • Table 95: Rest of World Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of World Historic Review for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of World 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Clinical Research End-Use, Pharma & Biotech Companies End-Use, Government Agencies End-Use and Academic Institutes End-Use for the Years 2020, 2026 & 2032
  • Table 98: Rest of World Recent Past, Current & Future Analysis for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 99: Rest of World Historic Review for SDS Poly Acrylamide Gel Electrophoresis by Offering - Instruments Offering, Reagents Offering and Gels Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 100: Rest of World 13-Year Perspective for SDS Poly Acrylamide Gel Electrophoresis by Offering - Percentage Breakdown of Value Sales for Instruments Offering, Reagents Offering and Gels Offering for the Years 2020, 2026 & 2032
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abcam PLC
  • Analytik Jena AG
  • Bio-Rad Laboratories, Inc.
  • EnCor Biotechnology
  • GenScript Biotech Corporation
  • Lonza Bioscience
  • Lonza Group Ltd.
  • Novus Biologicals LLC
  • PhosphoSolutions, Inc.
  • Promega Corporation

Table Information